![]() |
|
|||
|
Scientists are reporting a possible explanation for the bone loss that may occur following long-term use of a medicine widely used to treat epilepsy, bipolar disorder, and other conditions. The drug, valproate, appears to reduce the formation of two key proteins important for bone strength, they said. Their study, which offers a solution to a long-standing mystery, appears in ACS' monthly ...
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Study finds long-term use of bone-strengthening drugs increase risk of oesophageal ca | cancerfr | Bone Cancer | 0 | 09-10-2010 03:47 AM |
| Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer | cancerfr | Bone Cancer | 0 | 09-03-2010 07:26 AM |
| Long term use of oral bisphosphonates may double risk of esophageal cancer, study fin | cancerfr | Oral Cancer | 0 | 09-03-2010 07:26 AM |
| New study reveals PTPN2 gene loss causes bone cancer | cancerfr | Bone Cancer | 0 | 05-23-2010 02:52 AM |
| Long term, tamoxifen stops more cancer than Evista | cancerfr | Endometrial Cancer | 0 | 04-19-2010 10:28 PM |